Sep 2012

Case Series Demonstrating Improvement in Chronic Cutaneous Sarcoidosis Following Treatment With TNF Inhibitors

Author Affiliations

Author Affiliations: Department of Dermatology, University of Pennsylvania, Philadelphia.

Arch Dermatol. 2012;148(9):1097-1100. doi:10.1001/archdermatol.2012.1322

The tumor necrosis factor (TNF) inhibitors have been successfully used in the treatment of sarcoidosis, with improvement noted in recalcitrant cutaneous lesions.1,2

We report 5 cases of cutaneous sarcoidosis treated with TNF inhibitors, including 2 patients who had an excellent response to adalimumab and 3 patients demonstrating significant improvement in their cutaneous lesions after treatment with infliximab. The Table provides a summary of the clinical characteristics and prior treatments of these patients.

First Page Preview View Large
First page PDF preview
First page PDF preview